PE-22-28
FOR RESEARCH USE ONLY
Not for human or veterinary use. Not for therapeutic or diagnostic applications.
Not for human or veterinary use. Not for therapeutic or diagnostic applications.
Product Identification
- Compound Name: PE-22-28
- Synonyms: Spadin analog; TREK-1 inhibitor peptide; PE 22-28
- Sequence: 7-amino acid synthetic peptide derived from spadin core sequence (research analog)
- Category: Synthetic peptide (investigational TREK-1 channel modulator)
Chemical & Physical Data
- Molecular Formula: C35H54N12O9S (reference literature value, may vary by analog)
- Molecular Weight: ~802.9 g/mol (monoisotopic)
- Purity: ≥98% (HPLC) unless otherwise specified on batch COA
- Appearance: White to off-white lyophilized powder
- Solubility: Soluble in sterile aqueous solutions suitable for laboratory research preparation
Handling & Storage
- Storage (lyophilized): −20°C, protected from light and moisture
- Storage (reconstituted): Aliquot into suitable volumes and maintain frozen conditions
- Avoid repeated freeze-thaw cycles
- Handle using appropriate laboratory safety protocols and PPE
Research Classification
This compound is supplied as a laboratory reference material for analytical and experimental applications
investigating TREK-1 channel modulation, neurogenesis, and related mechanisms in preclinical models.
No claims are made regarding biological activity, safety, or efficacy in humans or animals. Not approved for
therapeutic, diagnostic, or clinical use.
All products are intended strictly for laboratory research conducted by qualified professionals.
The purchaser is responsible for ensuring compliance with all applicable laws and regulations.
The purchaser is responsible for ensuring compliance with all applicable laws and regulations.





